Antioxidant and antitumor effects of hydroxymatairesinol (HM-3000, HMR), a lignan isolated from the knots of spruce

European Journal of Cancer Prevention

Volumn 11, Issue SUPPL. 2, 2002, Pages

  Kangas, Lauri ^a   Saarinen, Niina ^a   Mutanen, Marja ^a   Ahotupa, Markku ^a   Hirsinummi, Riikka ^a   Unkila, Mikko ^a   Perälä, Merja ^a   Soininen, Pasi ^a   Laatikainen, Reino ^a   Korte, Helena ^a   Santti, Risto ^a  

^a Hormos Medical Ltd   (Finland)

Author keywords

Antioxidant; Cancer; Enterolactone; Functional food; Hydroxymatairesinol; Lignans

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CATENIN; BUTYLATED HYDROXYANISOLE; GLUCURONIDE; HM 3000; HYDROXYMATAIRESINOL; LIGNAN; PEROXY RADICAL; TROLOX C; UNCLASSIFIED DRUG; PLANT EXTRACT;

ANTINEOPLASTIC ACTIVITY; CONFERENCE PAPER; DRUG EFFECT; ENTEROHEPATIC CIRCULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTESTINE FLORA; LIPID PEROXIDATION; PRIORITY JOURNAL; SPRUCE; TUMOR GROWTH; URINARY EXCRETION; WEIGHT GAIN; ANIMAL; ARTICLE; BIOAVAILABILITY; C57BL MOUSE; COMPARATIVE STUDY; DISEASE MODEL; EXPERIMENTAL NEOPLASM; FEMALE; MALE; MOUSE; RANDOMIZATION; RAT; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; DISEASE MODELS, ANIMAL; FEMALE; LIGNANS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY;

EID: 0036701804     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Ahotupa M, Ruutu M, Mäntylä E (1996). Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins. Clin Biochem 29: 139-44.
2. Ahotupa M, Mäntylä E, Kangas L (1997). Antioxidant properties of the triphenylethylene antiestrogen drug toremifene. Naunyn-Schmiedeberg's Arch Pharmacol 356: 297-302.
3. Axelson M, Setchell KDR (1981). The excretion of lignans in rats - Evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett 123: 337-42.
4. Axelson M, Sjövall J, Gustafsson BE, Setchell KDR (1982). Origin of lignans in mammals and identification of a precursor from plants. Nature 298: 659-60.
5. Beherens J, von Kries JP, Kühl M, et al. (1996). Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382: 638-42.
6. De Gaetano G and Collaborative Group of the Primary Prevention Project (2001). Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomized trial in general practice. Collaborative group of the primary prevention project. Lancet 357: 89-95.
7. Ekman R (1976). Analysis of lignans in Norway spruce by combined gas chromatography-mass spectrometry. Holzforschung 30: 79-85.
8. Halliwell B (1994). Free radicals, antioxidants, and human disease: Curiosity, cause or consequence. Lancet 344: 721-4.
9. Ingram D, Sanders K, Kolybaba M, Lopez D (1997). Case-control study of phyto-oestrogens and breast cancer. Lancet 350: 990-4.
10. Jenab M, Thompson LU (1996). The influence of flaxseed and lignans on colon carcinogenesis and beta-glucuronidase activity. Carcinogenesis 17: 1343-8.
11. Korinek V, Barker N, Morin PJ, van Wichen D, et al. (1997). Constitutive transcriptional activation by β-catenin-Tcf-complex in APC-/-colon carcinoma. Science 275: 1784-7.
12. Laatikainen R, Niemitz M (2002) PERCH, An Integrated Software for Analysis of NMR Spectra in for Personal Computers. http://www. uku.fi/perch.html
13. 13C enriched metabolites from cell suspensions incubated in deuterated media. MagnReson Med 36: 359-65.
14. Landström M, Zhang JX, Hallmans G, et al. (1998). Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats. Prostate 36: 151-61.
15. Li D, Yee JA, Thompson LU, Yan L (1999). Dietary supplementation with secoisolariciresinol diglycoside reduces experimental metastasis of melanoma cells in mice. Cancer Lett 142: 91-6.
16. Mazur W, Adlercreutz H (1998). Natural and anthropogenic environmental oestrogens: The scientific basis of risk assessment. Naturally occurring oestrogens in food. Pure Appl Chem 70: 1759-76.
17. McGahon AJ, Martin SJ, Bissonette RP, et al. (1995) The end of the (cell) line: Methods for the study of apoptosis in vitro. In Cell Death (eds Schwartz LM, Osborne BA); Academic Press, San Diego, CA. pp. 153-81.
18. Morin PJ, Sparks AB, Korinek V, et al. (1997). Activation of β-catenin-Tcf-signaling in colon cancer by mutations in β-catenin or APC. Science 275: 1787-9.
19. Min mice: Relation to β-catenin and PKC isozymes. Carcinogenesis 21: 1167-73.
20. Min mice. Cancer Lett 161: 253-8.
21. Phipps WR, Martini MC, Lampe JW, Slavin JL, Kurzer MS (1993). Effect of flax seed ingestion on the menstrual cycle. J Clin Endocrinol Metab 77: 1215-19.
22. Pietinen P, Stumpf K, Männistö S, Kataja V, Uusitupa M, Adlercreutz H (2001). Serum enterolactone and risk of breast cancer: A case-control study in Eastern Finland. Cancer Epidemiol Biomarkers Prev 10: 339-44.
23. Ristola M, Repo H (1989). Luminol enhanced chemiluminescence of whole blood. APMIS 97: 503-12.
24. Saarinen NM, Wärri A, Mäkelä SI. et al. (2000). Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr Cancer 36: 207-16.
25. Saarinen NM, Huovinen R, Wärri A, et al. (2002). Uptake and metabolism of hydroxymatairesinol in relation to its anticarcinogenicity in DMBA-induced rat mammary carcinoma model. Nutr Cancer 41: 82-90.
26. Schroeter H, Williams RJ, Matin R, Iversen L, Rice-Evans CA (2000). Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein. Free Rad Biol Med 29: 1222-33.
27. Serraino M, Thompson LU (1992). The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. Nutr Cancer 17: 153-9.
28. Shultz TD, Bonorden WR, Seaman WR (1991). Effect of short-time flaxseed consumption on lignan and sex hormone metabolism in men. Nutrition Res 11: 1089-110.
29. Thompson LU, Seidl MM, Rickard SE, Orcheson, LJ, Fong HHS (1996). Antitumorigenic effect of a mammalian lignan precursors from flaxseed. Nutr Cancer 26: 159-65.